Table 2.

Regimen, courses, tumor response, and toxicity of induction chemotherapy

Patient	Gender	Age	Primary tumor	cT	cN	Clinical stage	ICT regimen	ICT courses	T-RR	N-RR	AE-neutropenia
1	Male	51	PPW	T2	N2c	IVA	TPF	2	PR	PR	Grade 2
2	Male	54	PS	T4a	N3b	IVB	TPF	2	PR	PR	Grade 4
3	Female	52	PPW	T3	N0	III	TPF	2	PR	-	Grade 3
4	Male	73	PS	T2	N1	III	TPF	1	PR	PR	Grade 4
5	Male	77	PS	T3	N1	III	TPF	2	PR	SD	Grade 3
6	Male	54	PS	T4a	N2b	IVA	TPF	2	PR	PR	Grade 4
7	Male	52	PS	T3	N3b	IVB	TPF	2	CR	PR	Grade 3
8	Male	73	PS	T4a	N2b	IVA	TPF	2	CR	PR	Grade 2
9	Female	72	PS	T2	N2b	IVA	PF	2	PR	PR	Grade 4
10	Male	76	PS	T3	N2c	IVA	TPF	2	CR	PR	Grade 2
11	Male	64	PS	T3	N0	III	TPF	2	PR	-	Grade 4

AE = adverse effect; CR = complete response; cN = clinical neck; cT = clinical tumor; ICT = induction chemotherapy; N-RR = neck lymph node response rate; PPW = posterior pharyngeal wall; PR = partial response; PS = pyriform sinus; SD = stable disease; T-RR = primary tumor response rate.